by Calcium citrate malate is an organic calcium supplement that allows effective calcium absorption and assists in maintaining bone density and joint mobility. It is extracted from malic acid and citric acid derived from fruits and combined with calcium to form calcium citrate malate. This supplement is highly bioavailable to the body compared to other calcium supplements. Some key advantages of calcium citrate malate include improved absorption rate, no gastrointestinal side effects, and enhanced bone mineralization. The growing geriatric population suffering from osteoporosis and arthritis has fueled the need for calcium citrate malate supplements in recent times.
The Global Calcium Citrate Malate Market is estimated to be valued at US$ 334.08 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the Calcium Citrate Malate Market Size are Omron Corporation, Texas Instruments Incorporated, ABB Limited, TE Connectivity Inc., Sick AG, Omega Engineering Inc. The key players dominating the market hold a significant market share and have well-established distribution networks spread across various countries. Omron Corporation is a leading player especially in developed regions and offers a wide array of calcium citrate malate supplements.
The growing demand for bone and joint health supplements due to the increasing prevalence of osteoporosis and arthritis across both developed and developing countries is fueling market growth. According to recent estimates, around 200 million people suffer from osteoporosis globally. Efficiency, convenience, and growing awareness about the nutrient benefits are also boosting the adoption of calcium citrate malate supplements.
The market is witnessing expansion into new regional territories driven by growing health consciousness. Manufacturers are investing in strategic partnerships and acquisitions to strengthen their international presence especially in Asia Pacific and Latin America which hold immense growth potential. Technology advancements resulting in new delivery forms like effervescent tablets and gummies are further supporting the global expansion of the calcium citrate malate market.
Market Key Trends
One of the key trends driving growth in the calcium citrate malate market is the rising demand for plant-based, clean label supplements. Consumers are increasingly preferring supplements derived from natural sources like fruits over artificial or chemically synthesized ingredients. As a result, manufacturers are focusing on developing organic, vegan, and non-GMO calcium citrate malate products using natural fruit acids and alkalizing agents. This shift towards clean label solutions is expected to define future innovations and expansion plans in the market over the coming years.
Porter’s Analysis
Threat of new entrants: It is low as calcium citrate malate market is quite established market. Established players dominate the market.
Bargaining power of buyers: It is moderate as there are few buyers in large scale with professional purchasing departments but threat is lower due to specialty nature of product.
Bargaining power of suppliers: It is high as raw materials for calcium citrate malate are limited and switching cost for buyers is high.
Threat of new substitutes: Threat is moderate as calcium supplements have small substitutes but no direct substitute for calcium citrate malate is available.
Competitive rivalry: Intense competition between major players to gain market share.
Geographical Regions
North America region accounts for the largest share of the global calcium citrate malate market in terms of value owing to robust healthcare infrastructure and awareness.
Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to rising disposable income, growing health concerns and increasing penetration of calcium supplements manufacturers in the region.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
